Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
Go back to Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs| (NASDAQ: BCTX) | Delayed: 3.63 +0.03 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.60 | 52 Week High | $ | |||
| Open | $3.68 | 52 Week Low | $ | |||
| Day High | $3.77 | P/E | N/A | |||
| Day Low | $3.61 | EPS | $ | |||
| Volume | 74,714 | |||||
| (NASDAQ: NTHI) | Delayed: 3.68 +0.02 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.66 | 52 Week High | $ | |||
| Open | $3.69 | 52 Week Low | $ | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.45 | EPS | $ | |||
| Volume | 188,718 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.75 -0.02 (2.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $1.37 | |||
| Open | $0.77 | 52 Week Low | $0.24 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $0.00 | |||
| Volume | 1,202,104 | |||||
